UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
ORIC Pharmaceuticals, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table below in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
P.O. BOX 8016, CARY, NC 27512-9903 |
ORIC Pharmaceuticals, Inc. | |
| Important Notice Regarding the | ||
| Availability of Proxy Materials | ||
|
Stockholders Meeting to be held on | ||
| June 17, 2022 | ||
| For Stockholders of record as of April 18, 2022 | ||
|
This communication presents only an overview of the more complete
proxy | ||
|
To view the proxy materials, and to obtain directions to attend
the meeting, | ||
|
To vote your proxy while visiting this site, you will need the 12
digit control | ||
|
Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet. | ||
|
| ||
|
|
||||
|
|
For a convenient way to view proxy materials and VOTE go to www.proxydocs.com/ORIC
Have the 12 digit control number located in the shaded box above available when you access the website and follow the instructions. |
| ||
|
|
||||
| If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year’s meeting, you must make this request on or before June 07, 2022.
To order paper materials, use one of the following methods. |
||||
|
|
|
||||||||
|
INTERNET |
TELEPHONE | |||||||||
| www.investorelections.com/ORIC | (866) 648-8133 | paper@investorelections.com | ||||||||
| When requesting via the Internet or telephone you will need the 12 digit control number located in the shaded box above. |
* If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located above) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material. |
|||||||||
| ORIC Pharmaceuticals, Inc. | ||||||
| Meeting Type: Annual Meeting of Stockholders | ||||||
| Date: | Friday, June 17, 2022 | |||||
| Time: | 8:00 AM, Pacific Time | |||||
| Place: | Annual Meeting to be held via live webcast | |||||
| Please visit www.proxydocs.com/ORIC for more details | ||||||
| You must register to attend the meeting online and/or participate at www.proxydocs.com/ORIC | ||||||
| SEE REVERSE FOR FULL AGENDA
|
||||||
ORIC Pharmaceuticals, Inc.
Annual Meeting of Stockholders
THE BOARD OF DIRECTORS RECOMMENDS A VOTE:
FOR ON PROPOSALS 1 AND 2
PROPOSAL
| 1. | Election of Directors |
1.01 Steven L. Hoerter
1.02 Angie You, Ph.D.
| 2. | Ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022 |
| 3. | Transact other business that may properly come before the Annual Meeting |